.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Baxter
Federal Trade Commission
Dow
Harvard Business School
Cantor Fitzgerald
Moodys
Citi
Accenture
UBS

Generated: September 22, 2017

DrugPatentWatch Database Preview

Timolol - Generic Drug Details

« Back to Dashboard

What are the generic sources for timolol and what is the scope of timolol freedom to operate?

Timolol
is the generic ingredient in eight branded drugs marketed by Akorn, Oak Pharms Inc, Usl Pharma, Apotex Inc, Bausch And Lomb, Merck, Watson Labs, Valeant Pharms Llc, Pacific Pharma, Teva, Sandoz, Fdc Ltd, Sandoz Inc, Hi Tech Pharma, Aton, Quantum Pharmics, Fougera, Mylan, and Wockhardt, and is included in forty-five NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for timolol. Three suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: timolol

Tradenames:8
Patents:3
Applicants:19
NDAs:45
Drug Master File Entries: see list15
Suppliers / Packagers: see list3
Bulk Api Vendors: see list23
Clinical Trials: see list204
Patent Applications: see list6,792
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:timolol at DailyMed

Pharmacology for Ingredient: timolol

Tentative approvals for TIMOLOL

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe0.5%SOLUTION;OPHTHALMIC
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
TIMOLOL MALEATE
timolol maleate
TABLET;ORAL072269-001Apr 11, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva
TIMOLOL MALEATE
timolol maleate
TABLET;ORAL072649-001Jun 16, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
Usl Pharma
TIMOLOL MALEATE
timolol maleate
TABLET;ORAL072002-001Apr 11, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
Fdc Ltd
TIMOLOL MALEATE
timolol maleate
SOLUTION/DROPS;OPHTHALMIC077259-002Apr 30, 2008AT1RXNoNo► Subscribe► Subscribe► Subscribe
Mylan
TIMOLOL MALEATE
timolol maleate
TABLET;ORAL072668-003Jun 8, 1990RXNoNo► Subscribe► Subscribe► Subscribe
Sandoz Inc
TIMOLOL MALEATE
timolol maleate
SOLUTION/DROPS;OPHTHALMIC074262-001Apr 28, 1995AT1RXNoYes► Subscribe► Subscribe► Subscribe
Pacific Pharma
TIMOLOL MALEATE
timolol maleate
SOLUTION/DROPS;OPHTHALMIC074746-001Mar 25, 1997ATRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
TIMOLOL MALEATE
timolol maleate
TABLET;ORAL072919-001Jul 31, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
TIMOLOL MALEATE
timolol maleate
TABLET;ORAL072550-001Apr 13, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
Merck
BLOCADREN
timolol maleate
TABLET;ORAL018017-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: timolol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Oak Pharms Inc
BETIMOL
timolol
SOLUTION/DROPS;OPHTHALMIC020439-001Mar 31, 1995► Subscribe► Subscribe
Oak Pharms Inc
BETIMOL
timolol
SOLUTION/DROPS;OPHTHALMIC020439-002Mar 31, 1995► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Cantor Fitzgerald
Johnson and Johnson
Moodys
Citi
Daiichi Sankyo
US Army
Fuji
QuintilesIMS
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot